AzTrials
AzTrials

Lumbar Spinal Stenosis (LSS)AtrophyLSSNCT04444739

Association Between Lumbar Muscle Atrophy, Sagittal Pelvic Alignment and Stenosis Grade in Patients With Degenerative Lumbar Spinal Stenosis

An observational study of Lumbar Spinal Stenosis (LSS), run by University Hospital, Basel, Switzerland at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is to evaluate the correlation between muscle atrophy (MA), sagittal alignment, and stenosis degree in patients with lumbar spinal Stenosis (LSS). From existing radiological images, specific radiographic parameters will be extracted. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Lumbar Spinal Stenosis (LSS)
What is being tested?
radiographic data collection
How many people
165 participants
Where
1 siteSwitzerland
Study dates
3 Feb 2020to 31 Dec 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All patients who visited Orthopaedics and Traumatology outpatient clinic at University Hospital Basel for clinical and radiological consultation regarding their lumbar spine between 01.01.2018 and 31.12.2019.

Who may be able to join

  • Diagnosis of degenerative lumbar spinal stenosis
  • Upright standing sagittal plane X-ray of lumbar spine with clear visibility of pelvis sacrum and femoral head
  • MRI of the lumbar region with clear visibility of different muscle atrophy grade
  • Consent that health related information can be used for research was signed

Who cannot join

  • Other spinal disease such as severe scoliosis, fracture, spondylolisthesis and ankylosing spondylitis.
  • Neuromuscular diseases such as M.Parkinson or multiple sclerosis
  • Previous surgery of the spine
  • Infection and/or malignancy tumor with involvement of the bony or soft tissue structures of the spine
  • Presence of a documented consent dissent.

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Orthopaedics and Traumatology, University Hospital Basel

    Basel, 4031

Other trials in Switzerland

About this study

Official title: AtrophyLSS - Association Between Lumbar Muscle Atrophy, Sagittal Pelvic Alignment and Stenosis Grade in Patients With Degenerative Lumbar Spinal Stenosis

This study is to evaluate the correlation between muscle atrophy (MA), sagittal alignment, and stenosis degree in patients with lumbar spinal Stenosis (LSS). From existing radiological images, specific radiographic parameters will be extracted. General Information (Age, sex, levels of stenosis, duration of symptoms) will be extracted from patient files.

Being tested
radiographic data collection
Keywords
paraspinal muscle atrophy (MA), sagittal pelvic alignment, degenerative spine diseases, stenosis grade (SG), degenerative LSS, Goutallier classification
Medical subject headings
Spinal Stenosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • radiographic data collectionOther

    From existing radiological Images (upright standing X-ray and supine MRI of the lumbar spine), specific radiographic parameters will be extracted

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Severity of muscle atrophy (MA) from supine Magnetic Resonance Imaging (MRI) of lumbar spine

    Muscle atrophy stage will be observed using Goutallier classification

    • Stage 0: No fatty infiltration
    • Stage 1: Few fatty streaks within the muscle
    • Stage 2: Less than 50% fat within the muscle
    • Stage 3: 50% of fat within the muscle
    • Stage 4: more than 50% fat with in the muscle. The MA stage will be observed in MRI of 5 lumbar disc levels (L1-S1). The MA stage of patients will be calculated as average stage of five lumbar segments.

    Measured: single time-point at baseline

  2. Pelvic incidence (PI): Pelvic alignment from standard upright standing sagittal plane X-ray of lumbar spine with clear visibility of pelvis sacrum and femoral heads

    Pelvic incidence (PI): The angle between the line perpendicular to the sacral endplate at its midpoint and a line connecting this point to the axis of the femoral head.

    Measured: single time-point at baseline

  3. Severity of stenosis from supine MRI of lumbar spine

    Stenosis grade will be observed using Schizas classification (Schizas et al., 2010)

    • Grade 1: Dural sac party occupied by the rootlets; Cerebrospinal fluid clearly visible; No stenosis
    • Grade 2: Rootlets occupy whole dural sac; Some cerebrospinal fluid visible; Moderate stenosis.
    • Grade 3: Rootlets not visible; No cerebrospinal fluid visible; Epidural fat posteriorly; Severe stenosis.
    • Grade 4: Rootlets not visible; No cerebrospinal fluid; No epidural fat; Extreme Stenosis. The most severe level will be regarded as the stenosis grade of the patients.

    Measured: single time-point at baseline

  4. Pelvic tilt (PT): Pelvic alignment from standard upright standing sagittal plane X-ray of lumbar spine with clear visibility of pelvis sacrum and femoral heads

    Pelvic tilt (PT): The angle formed by a vertical line through the center of the femoral heads and the line from the center of the femoral axis and the midpoint of the sacral end plate.

    Measured: single time-point at baseline

  5. Sacral slope (SS): Pelvic alignment from standard upright standing sagittal plane X-ray of lumbar spine with clear visibility of pelvis sacrum and femoral heads

    Sacral slope (SS): The angle formed between the horizontal and the sacral end plate.

    Measured: single time-point at baseline

  6. Lumbar lordosis (LL): Pelvic alignment from standard upright standing sagittal plane X-ray of lumbar spine with clear visibility of pelvis sacrum and femoral heads

    Lumbar lordosis (LL): The sagittal angle formed between the superior end plate of L1 and the sacral end plate

    Measured: single time-point at baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jun 2020
  2. Study start3 Feb 2020
  3. Primary completion30 Sep 2020
  4. Study completion31 Dec 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
165 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04444739
Sponsor's protocol ID
2020-00150; ch20Muendermann4
Acronym
AtrophyLSS
Status last verified
Jun 2021
First submitted
16 Jun 2020
Last updated
18 Jun 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Lumbar Spinal Stenosis (LSS), run by University Hospital, Basel, Switzerland at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Severity of muscle atrophy (MA) from supine Magnetic Resonance Imaging (MRI) of lumbar spine (time frame: single time-point at baseline). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in